<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmaceuticalprojects.com/news/biocon-secures-european-commission-approval-for-pertuzumab-biosimilar-pebrilzo-in-her2-positive-breast-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmaceutical Plant Projects</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-18T13:42:23.161Z</news:publication_date>
      <news:title>Biocon Secures European Commission Approval for Pertuzumab Biosimilar Pebrilzo in HER2-Positive Breast Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmaceuticalprojects.com/news/nanoform-partners-with-european-cdmo-to-manufacture-high-concentration-biologics-under-gmp-in-germany</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmaceutical Plant Projects</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-18T13:38:53.719Z</news:publication_date>
      <news:title>Nanoform Partners With European CDMO to Manufacture High-Concentration Biologics Under GMP in Germany</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmaceuticalprojects.com/news/lotte-biologics-signs-first-commercial-manufacturing-agreement-for-songdo-plant-1-in-south-korea</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmaceutical Plant Projects</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T13:24:07.758Z</news:publication_date>
      <news:title>LOTTE Biologics Signs First Commercial Manufacturing Agreement for Songdo Plant 1 in South Korea</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmaceuticalprojects.com/news/johnson-and-johnson-acquires-ollin-biosciences-for-usd-2-2-billion-to-advance-phase-3-retinal-drug-in-the-us</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmaceutical Plant Projects</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T13:14:41.732Z</news:publication_date>
      <news:title>Johnson &amp; Johnson Acquires Ollin Biosciences for $2.2 Billion to Advance Phase 3 Retinal Drug in the US</news:title>
    </news:news>
  </url>
</urlset>
